心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）

2018-12-20 AHA 指南重点更新摘要项目组 American Heart Association JN0896.

心肺复苏心血管急救高级生命支持

2015 年，国际复苏联络委员会 (ILCOR) 开始采用持续证据评估 (CEE) 流程。此流程用于快速分析同行评审的已发表的复苏研究以及心肺复苏 (CPR) 和心血管急救 (ECC) 科学与治疗建议 (CoSTR) 声明的国际共识的发展。持续证据评估旨在缩短复苏证据公布与转化成 ILCOR 成员（如美国心脏协会 (AHA)）所提供指南建议之间的间隔时间。基于这些年度 ILCOR CoSTR 总结

中文标题：

2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）

发布机构：

AHA 指南重点更新摘要项目组

发布日期：

2018-12-20

简要介绍：

2015 年，国际复苏联络委员会 (ILCOR) 开始采用持续证据评估 (CEE) 流程。此流程用于快速分析同行评审的已发表的复苏研究以及心肺复苏 (CPR) 和心血管急救 (ECC) 科学与治疗建议 (CoSTR) 声明的国际共识的发展。持续证据评估旨在缩短复苏证据公布与转化成 ILCOR 成员（如美国心脏协会 (AHA)）所提供指南建议之间的间隔时间。基于这些年度 ILCOR CoSTR 总结陈述，美国心脏协会心血管急救委员会将出版关于心肺复苏及心血管急救的年度指南重点更新。这些摘要总结了高级心血管生命支持 (ACLS) 及儿科高级生命支持 (PALS) 编写小组所出版的 2018 美国心脏协会指南重点更新中的变更。 

拓展指南：与心肺复苏相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）)] GetToolGuiderByIdResponse(projectId=1, id=e34af1c0016838c7, title=2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）, enTitle=, guiderFrom=American Heart Association JN0896., authorId=null, author=, summary=2015 年，国际复苏联络委员会 (ILCOR) 开始采用持续证据评估 (CEE) 流程。此流程用于快速分析同行评审的已发表的复苏研究以及心肺复苏 (CPR) 和心血管急救 (ECC) 科学与治疗建议 (CoSTR) 声明的国际共识的发展。持续证据评估旨在缩短复苏证据公布与转化成 ILCOR 成员（如美国心脏协会 (AHA)）所提供指南建议之间的间隔时间。基于这些年度 ILCOR CoSTR 总结, cover=, journalId=null, articlesId=null, associationId=1744, associationName=AHA 指南重点更新摘要项目组, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2015 年，国际复苏联络委员会 (ILCOR) 开始采用持续证据评估 (CEE) 流程。此流程用于快速分析同行评审的已发表的复苏研究以及心肺复苏 (CPR) 和心血管急救 (ECC) 科学与治疗建议 (CoSTR) 声明的国际共识的发展。持续证据评估旨在缩短复苏证据公布与转化成 ILCOR 成员（如美国心脏协会 (AHA)）所提供指南建议之间的间隔时间。基于这些年度 ILCOR CoSTR 总结陈述，美国心脏协会心血管急救委员会将出版关于心肺复苏及心血管急救的年度指南重点更新。这些摘要总结了高级心血管生命支持 (ACLS) 及儿科高级生命支持 (PALS) 编写小组所出版的 2018 美国心脏协会指南重点更新中的变更。 </div> <div><br> </div>拓展指南：<strong>与<font color="red">心肺复苏</font>相关指南：</strong><br><ul><li><a title="2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=aba3c1c0016e0193">2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用</a></li> <li><a title="2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=69e961c001661580">2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）</a></li> <li><a title="2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=d57e01c001661a32">2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）</a></li> <li><a title="成人院内心肺复苏质量控制临床实践专家共识" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=6f7e51c0016a04e5">成人院内心肺复苏质量控制临床实践专家共识</a></li> <li><a title="2018中国心肺复苏培训专家共识" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=95b021c001598a82">2018中国心肺复苏培训专家共识</a></li> 更多信息请点击：<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%82%BA%E5%A4%8D%E8%8B%8F">有关心肺复苏更多指南</a></ul>, tagList=[TagDto(tagId=70, tagName=心肺复苏), TagDto(tagId=48414, tagName=心血管急救), TagDto(tagId=82772, tagName=高级生命支持)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10560, appHits=863, showAppHits=5, pcHits=7567, showPcHits=3084, likes=224, shares=49, comments=21, approvalStatus=1, publishedTime=Fri Jan 04 23:58:27 CST 2019, publishedTimeString=2018-12-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 04 23:58:27 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 04:35:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）)])
2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）
下载请点击：
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1187398, encodeId=8f61118e3984a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:41:53 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357437, encodeId=68f435e437bb, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:57 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357436, encodeId=29c635e4366e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:52 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357435, encodeId=8fe735e4353a, content=学习了新知识学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:47 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357434, encodeId=bfc335e4342a, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:39 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2022-01-23 胡国宏

    #学习#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1187398, encodeId=8f61118e3984a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:41:53 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357437, encodeId=68f435e437bb, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:57 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357436, encodeId=29c635e4366e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:52 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357435, encodeId=8fe735e4353a, content=学习了新知识学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:47 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357434, encodeId=bfc335e4342a, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:39 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了长知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1187398, encodeId=8f61118e3984a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:41:53 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357437, encodeId=68f435e437bb, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:57 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357436, encodeId=29c635e4366e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:52 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357435, encodeId=8fe735e4353a, content=学习了新知识学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:47 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357434, encodeId=bfc335e4342a, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:39 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1187398, encodeId=8f61118e3984a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:41:53 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357437, encodeId=68f435e437bb, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:57 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357436, encodeId=29c635e4366e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:52 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357435, encodeId=8fe735e4353a, content=学习了新知识学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:47 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357434, encodeId=bfc335e4342a, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:39 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了新知识学习了长知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1187398, encodeId=8f61118e3984a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:41:53 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357437, encodeId=68f435e437bb, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:57 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357436, encodeId=29c635e4366e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:52 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357435, encodeId=8fe735e4353a, content=学习了新知识学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:47 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357434, encodeId=bfc335e4342a, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:10:39 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了长知识

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）

欧洲复苏委员会(ERC,European Resuscitation Council) · 2018-11-26

2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用

暂未更新 · 2018-11-20

2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）

美国心脏协会(AHA,American Heart Association) · 2018-11-05

2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）

美国心脏协会(AHA,American Heart Association) · 2018-11-05

成人院内心肺复苏质量控制临床实践专家共识

国内急诊/重症相关专家小组（统称） · 2018-08-30

2018 AHA科学声明：婴儿以及儿童心脏病患者心肺复苏

美国心脏协会(AHA,American Heart Association) · 2018-04-23